Intec Pharma: Hits two-month high on cannabinoid research deal
09/12/2020 12:52
** Shares of biotech co NTEC.O surge ~58% to a two-month
high of $5.55 premarket
** NTEC among the most actively traded stocks across U.S.
exchanges
** Co enters into a cannabinoid research partnership with
London-based company GW Pharma for an undisclosed research
program that will employ its drug delivery system Accordion Pill
urn:newsml:reuters.com:*:nPn3w3MK5a
** About 820,000 shares change hands, about double its 25
day moving avg. volume
** Stock down about 65% this year, as of last close
(Reporting by Medha Singh in Bengaluru)
((medha.singh@thomsonreuters.com))